Explore why pharmacists are concerned about Narrow Therapeutic Index (NTI) generics, the risks of drug substitution, and how bioequivalence impacts patient safety.
Read more
While generics save billions, some patients experience real side effects after switching. Learn why bioequivalence doesn't always mean identical results, especially for thyroid, seizure, and blood-thinner medications.
Read more
Combination NTI drugs offer powerful treatment for complex conditions but face major barriers to generic availability. With no approved fixed-dose combinations in the U.S., patients face higher costs, increased monitoring, and greater risk of adverse events after generic switches.
Read more